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The myristoylated alanine-rich C kinase substrate, or MARCKS protein, is a widely expressed, prominent substrate for
protein kinase C. Although the exact function of MARCKS has not been elucidated, targeted disruption of the MARCKS
gene (Macs) in mice has shown that MARCKS plays a crucial role in the development of the central nervous system. Mice
de®cient in MARCKS exhibited universal perinatal death with defects in neurulation, fusion of the cerebral hemispheres,
formation of the great forebrain commissures, and retinal and cortical lamination (Stumpo et al., Proc. Natl. Acad. Sci.
USA 92, 944±948, 1995). In the present studies, a transgene consisting of approximately 3.4 kb of promoter from the
human MARCKS gene (MACS), with an epitope tag sequence inserted at the carboxyl terminus of the MARCKS coding
region, was able to complement completely MARCKS de®ciency in mice. Thus, the human transgene contained all of the
elements necessary for normal developmental expression of MARCKS. To test the importance of MARCKS myristoylation
to its developmental role, an otherwise identical transgene was constructed in which the glycine at the amino terminus
of MARCKS was mutated to an alanine. This mutation, which resulted in the expression of nonmyristoylated MARCKS,
was successful in partially rescuing the Macs null phenotype. Speci®cally, about 25% of these mice survived the perinatal
period; these survivors appeared to develop normally except for slightly decreased body size. In both the survivors and the
nonsurvivors, all of the known anatomical defects associated with MARCKS de®ciency were corrected by expression of
the nonmyristoylated human protein. These results indicate that myristoylation of MARCKS is not required for the protein
to correct many of the developmental abnormalities characteristic of its de®ciency. q 1996 Academic Press, Inc.
INTRODUCTION MARCKS protein (for reviews see Aderem, 1992; Black-
shear, 1993), is one of the most prominent of these cellular
PKC substrates. It is characterized by amino-terminal my-A wide variety of cellular responses, including differentia-
ristoylation, in addition to heat stability and anomaloustion, mitogenesis, and hormone secretion, are mediated by
migration on SDS±polyacrylamide gels. There are threethe family of isoenzymes known collectively as protein ki-
highly conserved regions in all MARCKS proteins identi®ednase C (PKC) (Nishizuka, 1984, 1986, 1992; Goodnight et
to date: A consensus sequence for myristoylation at theal., 1994). However, little is understood about the mecha-
amino-terminus which is in part responsible for the mem-nisms by which PKC controls these processes, or the precise
brane association of the protein; a region of conserved se-roles of the phosphorylated substrates of PKC in mediating
quence at the single site of intron splicing; and a phosphory-these events.
lation site domain containing the three or four serinesThe myristoylated alanine-rich C kinase substrate, or
known to be phosphorylated by PKC. The phosphorylation
site domain has also been shown to interact with calmodu-
lin, actin, and cellular membranes, in all cases in a phos-1 Current address: Department of Medicine, Division of Nephrol-
ogy, Duke University Medical Center, Durham, NC 27710. phorylation-inhibited manner.
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12CA5 (Fig. 1B). Insertion of the epitope was achieved by site-To date, no precise function has been de®ned for
directed mutagenesis (Amersham, Arlington Heights, IL), accordingMARCKS in cells. However, targeted disruption of the gene
to the manufacturer's protocol; its presence in frame was con®rmedencoding MARCKS in mice (Macs) has implicated the pro-
by dideoxy sequencing (Sanger et al., 1977). This epitope is recog-tein in the development of the central nervous system and
nized by monoclonal antibody 12CA5 (Berkeley Antibody Co.,postnatal viability (Stumpo et al., 1995). MARCKS-de®cient
Richmond, CA).
mice exhibited universal perinatal death as well as high To generate the construct MACS(A2/G2)-12CA5 (Fig. 1C), the
frequencies of exencephaly and omphalocele, failure of fu- amino-terminal glycine in the MARCKS protein was changed to
sion of the cerebral hemispheres, agenesis of the corpus an alanine using the Altered Sites oligonucleotide-directed in vitro
callosum and other forebrain commissures, and defects in mutagenesis kit from Promega (Madison, WI). Creation of the mu-
cortical and retinal lamination. These defects point to a tation was con®rmed by dideoxy sequencing (Sanger et al., 1977).
Thus, this construct differs from MACS-12CA5 in only two nucleo-potential role for MARCKS in cell±cell interactions or cell
tides, which result in the expression of epitope-tagged MARCKSmigration during central nervous system development.
that differed from MARCKS-12CA5 by only a single amino acid.In the present studies, we have attempted to complement
Transient transfection of LM/TK0 cells. Mouse LM/TK0 cells,the developmental defects present in MARCKS-de®cient
which lack endogenous MARCKS mRNA and protein (Stumpo etanimals through the expression of a transgene consisting
al., 1989), were grown in Dulbecco's modi®ed Eagle's mediumof the intact human MARCKS gene (MACS) containing a
(DMEM) supplemented with 10% (v/v) heat-inactivated fetal calf
hemagglutinin epitope tag sequence at the carboxyl-termi- serum, 2 mM glutamine, 100 units/ml penicillin, and 100 mg/ml
nus. We show that this construct, which contains the entire streptomycin and plated at a density of approximately 1.9 1 106
human mRNA coding sequence as well as 3.4 kb of pro- cells/100 mm plate. The following day, the cells were transfected
moter and the single intron, is capable of fully complement- with either 7.5 kb MACS or MACS-12CA5 using 200 mg/ml DEAE-
ing the MARCKS-de®ciency phenotype in mice. We then dextran as described (Lopata et al., 1984).
In vivo phosphorylation and immunoprecipitation of MARCKSinvestigated the importance of MARCKS myristoylation to
proteins. Con¯uent plates of LM/TK0 cells transiently trans-its developmental role by attempting to rescue the Macs
fected with 10 mg of either 7.5 kb MACS or MACS-12CA5 were0/0 mice with a transgene expressing nonmyristoylated
serum-starved overnight in DMEM containing 1% bovine serumhuman MARCKS. Our data indicate that the myristoyl
albumin (BSA, lyophilized and crystallized; Sigma, St. Louis, MO),modi®cation of MARCKS is important for postnatal sur-
2 mM glutamine, 100 units/ml penicillin, and 100 mg/ml strepto-vival; 75% of the Macs0/0 animals that expressed nonmy-
mycin. Cells were labeled for 2 hr in 0.2 mCi/ml [ortho-32P]phos-
ristoylated human MARCKS died in the immediate perina- phate as described (Blackshear et al., 1986), followed by treatment
tal period. However, all of the known anatomical defects with 1.6 mM phorbol 12-myristate 13-acetate (PMA) in 0.01% (v/
associated with MARCKS de®ciency were corrected by ex- v) dimethyl sulfoxide, or the same concentration of dimethyl sulf-
pression of the nonmyristoylated human protein, and 25% oxide as a control, for 10 min. The cells were washed twice with
of the animals expressing this protein survived. These re- ice-cold buffer containing 100 mM NaCl, 5 mM KCl, 1 mM CaCl2,
sults suggest that myristoylation of MARCKS is necessary 1 mM MgSO4, 25 mM NaHCO3, 10 mM Hepes, and 25 mM glucose,
and harvested in 2 ml of lysis buffer as described (Spizz and Black-for some but not all of the protein's functions during devel-
shear, 1996). The samples were then immunoprecipitated with ei-opment.
ther the polyclonal antibody to the amino-terminus of MARCKS
(Lobaugh and Blackshear, 1990) or the monoclonal antibody 12CA5
as described (Spizz and Blackshear, 1996).
MATERIALS AND METHODS Generation of transgenic mice. The XbaI/XmaI fragments of
MACS-12CA5 (Fig. 1B) and MACS(A2/G2)-12CA5 (Fig. 1C) con-
taining epitope-tagged human MARCKS sequences were isolatedConstruction of transgenic vectors MACS-12CA5 and
by agarose gel electrophoresis and further puri®ed using GeneMACS(A2/G2)-12CA5. A clone encompassing the human gene en-
Clean (Bio 101, Inc.). This DNA was used for injection into thecoding MARCKS (MACS) was isolated as described (Harlan et al.,
pronuclei of fertilized mouse eggs from B6SJLF1/J mice by standard1991). A 7.5-kb fragment was identi®ed that hybridized to the hu-
procedures (Gordon et al., 1980). Female mice expressing theman MARCKS cDNA; this fragment was isolated by agarose gel
MACS-12CA5 transgene or the MACS(A2/G2)-12CA5 transgeneelectrophoresis and further puri®ed by Gene Clean (Bio 101, Inc.,
were identi®ed by Southern blotting (see below), using a probe thatVista, CA). This 7.5-kb restriction fragment was subcloned into the
distinguishes the transgene from the endogenous gene (Harlan etBamHI site of Bluescribe (Stratagene, La Jolla, CA) to produce the
al., 1991). These were then mated to C57BL/6J males heterozygousclone 7.5 kb MACS (Fig. 1A). Restriction fragment and sequencing
for the disrupted mouse Macs allele (Stumpo et al., 1995). Theanalysis of the clone revealed the presence of approximately 3.4 kb
resulting progeny that both expressed the MACS-12CA5 transgeneof the MACS 5* ¯anking region, as well as the entire mRNA coding
and were heterozygous for the disrupted Macs allele were matedsequence, the single intron, and approximately 0.6 kb of 3* ¯anking
to create mice that expressed the MACS-12CA5 transgene, but wereregion.
homozygous for the disrupted Macs allele. Similar mating strate-An epitope tag consisting of a 9-amino-acid peptide derived from
gies were employed with mice that expressed the MACS(A2/G2)-in¯uenza virus hemagglutinin (Kolodjiej and Young, 1991) was in-
12CA5 transgene and were heterozygous for the disrupted Macstroduced in-frame between nucleotides 1289 and 1290 in the car-
allele.boxyl terminal coding region of the 7.5 kb MACS construct (Harlan
et al., 1991), ®ve codons 5* of the stop codon, yielding MACS- Southern blot analysis. DNA was prepared from mouse tail
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FIG. 1. Construction of transgenic vectors MACS-12CA5 and MACS(A2/G2)-12CA5. A 7.5-kb BglII fragment isolated from a clone
encoding human MARCKS (MACS) was subcloned into the BamHI site of Bluescribe (BS/; Stratagene) to produce 7.5 kb MACS (A). An
oligonucleotide encoding a 9-amino-acid peptide from in¯uenza virus hemagglutinin was introduced in-frame between nucleotides 1289
and 1290 in the carboxy-terminal coding region of 7.5 kb MACS (A) to yield MACS-12CA5 (B). MACS(A2/G2)-12CA5 (C) was created by
changing the amino-terminal glycine of 7.5 kb MACS (A) to an alanine by site-directed mutagenesis.
samples and digested with either EcoRI (detection of MACS-12CA5 brains were removed immediately after the animals were euthan-
ized with CO2, rinsed in ice-cold PBS, and homogenized using aand MACS(A2/G2)-12CA5 transgenes) or HindIII (detection of nor-
mal and disrupted Macs alleles), and separated on a 0.8% agarose Polytron (Kinematica) in 2±3 ml of the buffer described above for
the preparation of mouse tissue homogenates, except that the Tri-gel. The DNA was transferred to Nytran (Schleicher & Schuell,
Keene, NH) and probed with a 1.1-kb EcoRI fragment of the human ton X-100 was not included. The resulting homogenates were sub-
jected to ultracentrifugation at 107,000g for 40 min at 47C (TLAgenomic MACS clone (detection of MACS-12CA5 and MACS(A2/
G2)-12CA5 transgenes) (Harlan et al., 1991), or a 2.1-kb HindIII/ 100.3 rotor, Beckman Instruments, Fullerton, CA). The supernatant
fraction was removed, and the particulate fraction was resuspendedSstI fragment of the mouse genomic Macs clone (detection of nor-
mal and disrupted Macs alleles). in a volume of buffer equal to the starting volume that contained
0.6% Triton X-100 by sonication, and incubated on ice for 30 minPreparation of mouse tissue homogenates. Organs from mice
expressing the MACS-12CA5 transgene were removed and rapidly with frequent resuspension. This membrane suspension was centri-
fuged at 16,000g for 15 min at 47C, and the resulting supernatantplaced in liquid nitrogen after the animals were euthanized with
CO2 . The frozen tissues were ground to a ®ne powder under liquid was taken as the particulate fraction. Soluble and particulate frac-
tions were then boiled for 10 min, centrifuged at 16,000g for 15nitrogen using a mortar and pestle. The resulting tissue powder
was homogenized using a Polytron (Kinematica, GmbH, Lucerne, min at 47C, and the supernatants containing the heat-stable pro-
teins were combined with 1/5 vol SDS sample buffer, boiled for 3Switzerland) in 2 ml of an ice-cold buffer containing 50 mM b-
glycerophosphate (pH 8.2), 250 mM sucrose, 1 mM EDTA, 1 mM min, and subjected to SDS±PAGE and Western blotting (see below).
Western blot analysis. Proteins from SDS±polyacrylamide gelsEGTA, 1 mM dithiothreitol, 10 mM benzamidine±HCl, 1 mM phe-
nylmethylsulfonyl ¯uoride, 2 mM pepstatin, 2 mM leupeptin, and were transferred to nitrocellulose and blocked in a solution of 3%
(w/v) nonfat dry milk in TBS/T (10 mM Tris±HCl (8), 154 mM0.6% Triton X-100. The homogenates were centrifuged at 4400g
for 30 min at 47C. The resulting supernatants were boiled for 10 NaCl, 0.05% (v/v) Tween 20) at room temperature for 1 hr as pre-
viously described (Swierczynski and Blackshear, 1995). Blots weremin and centrifuged at 11,000g for 30 min at 47C. The heat-stable
proteins remaining in the supernatant were precipitated with 25% then incubated with either monoclonal antibody 12CA5, which
recognizes the hemagglutinin epitope tag sequence (Berkeley Anti-(w/v) trichloroacetic acid, washed with acetone (0207C), and resus-
pended in phosphate-buffered saline (PBS) with 1/4 vol SDS sample body Co., Richmond, CA) at a 1:800 dilution in TBS/T or a poly-
clonal antibody to an amino-terminal MARCKS peptide (Lobaughbuffer (1.5 M sucrose, 6% (w/v) SDS, 500 mM dithiothreitol, 60 mM
EDTA, 0.006% (w/v) pyronin Y), boiled for 3 min, and subjected to and Blackshear, 1990). As a secondary antibody, either goat anti-
mouse (for the 12CA5 monoclonal antibody) or goat anti-rabbit (forSDS±polyacrylamide gel electrophoresis (SDS±PAGE) and Western
blotting (see below). the polyclonal MARCKS antiserum) IgG conjugated to horseradish
peroxidase (Bio-Rad, Richmond, CA) was used at a 1:5000 dilutionSubcellular fractionation of mouse brain homogenates. Mouse
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in TBS/T. Chemiluminescence (ECL kit, Amersham) was used for
detection of immunoreactive proteins. For some experiments,
color-reactive proteins were developed in a solution of TBS, 17%
(v/v) methanol, 0.05% horseradish peroxidase color development
reagent (Bio-Rad), and 0.015% (v/v) H2O2 .
Histological analysis. Mouse tissues were removed and placed
in Bouin's ®xative (Polysciences, Inc., Warrington, PA) for 48 hr at
room temperature. The ®xed tissues were washed in 70% (v/v)
ethanol at room temperature for several days, with several changes
of the washing solution. The tissues were then embedded in paraf-
®n, sectioned (5 mm), and stained with hematoxylin and eosin as
previously described (Stumpo et al., 1995).
Immunohistochemistry. For immunohistochemistry using the
12CA5 monoclonal antibody, embryos at Embryonic Day (E) 9.5
(where E 0.5 represents the date of vaginal plugging) were removed,
and the genotype determined using the caudal half of the embryo FIG. 3. Tissue-speci®c expression and subcellular fractionation of
as described above for tail blotting. The cranial halves of the em- MARCKS-12CA5 in mice. Tissue extracts were prepared from a
bryos were ®xed in 4% paraformaldehyde for 16 hr at 47C, frozen mouse expressing the MACS-12CA5 transgene as described under
in isopentane/acetone/dry ice, and then processed for frozen section Materials and Methods. The MARCKS proteins in the tissue sam-
immunohistochemistry essentially as previously described (La- ples were precipitated with 25% TCA, and equal volumes from
Mantia et al., 1993). Sections (10 mm) were permeabilized with two each tissue, with the exception of brain where 25% of the volume
10-min washes in a TBS solution containing 0.2% Triton X-100; was loaded, were subjected to SDS±PAGE, transferred to nitrocellu-
they were then incubated with 12CA5 at a 1:3000 dilution for 16 lose, and probed with a monoclonal antibody raised against the
hr at 47C and then stained with secondary antibody (FITC-labeled hemagglutinin epitope tag (A). The arrow indicates the position of
goat anti-mouse IgG; Calbiochem, La Jolla, CA) for 30 min at room epitope-tagged MARCKS. In B, brain homogenates were separated
temperature. Fluorescence microscopy and photography were per- into membrane (M) and cytosolic (C) fractions by ultracentrifuga-
formed as previously described (Blackshear et al., 1996). tion. The particulate fraction was resuspended in the original vol-
ume of homogenization buffer, and then equal volumes were sub-
jected to SDS±PAGE, transferred to nitrocellulose, and probed with
a polyclonal antibody raised against the amino-terminus ofRESULTS
MARCKS. The top arrow indicates MARCKS-12CA5; the bottom
arrow indicates endogenous mouse MARCKS.7.5 kb MACS and MACS-12CA5 are expressed in LM/
TK0 cells. In order to ensure that MARCKS proteins were
expressed from constructs 7.5 kb MACS and MACS-12CA5,
we performed in vivo phosphorylation and immunoprecipi-
tation experiments in transiently transfected LM/TK0 cells;
these cells ordinarily lack MARCKS mRNA and protein
(Stumpo et al., 1989). Cells transfected with 7.5 kb MACS
expressed a phosphoprotein that was recognized by the poly-
clonal antibody raised against the amino terminus of
MARCKS (Lobaugh and Blackshear, 1990) (Fig. 2); similarly,
cells transfected with MACS-12CA5 expressed a phospho-
protein that was recognized by the antibody (12CA5) to the
hemagglutinin epitope tag (Berkeley Antibody Co.) (Fig. 2).FIG. 2. Expression of 7.5 kb MACS and MACS-12CA5 transiently
Both proteins exhibited the characteristic anomalous migra-transfected in LM/TK0 cells. LM/TK0 cells, which do not express
tion of human MARCKS on 7.2% SDS±PAGE gels, withendogenous MARCKS, were transiently transfected with 10 mg of
either 7.5 kb MACS or MACS-12CA5 DNA. The cells were serum- apparent Mr of approximately 94 1 103.
starved overnight and then labeled with 0.2 mCi/ml [ortho-32P]- 3.4 kb of 5*-¯anking MACS sequence promotes normal
phosphate for 2 hr. Following treatment with control conditions tissue distribution of human MARCKS. Of four lines of
(C) or 1.6 mM PMA for 10 min, the cells were homogenized and mice generated that expressed detectable human MARCKS
subjected to immunoprecipitation with preimmune serum (for 7.5 DNA, two were selected for further analysis based on high
kb MACS; P) or nonimmune ascites ¯uid (for MACS-12CA5; P), level expression of the MACS-12CA5 transgene. As deter-
and either a polyclonal antibody raised against a MARCKS amino-
mined by Western blot analysis of tissue homogenates pre-terminal peptide (7.5 kb MACS; I) or a monoclonal antibody raised
pared from various organs, the 3.4 kb of 5*-¯anking regionagainst the hemagglutinin epitope tag (MACS-12CA5; I). The re-
of MACS was suf®cient to drive essentially normal tissuesulting autoradiograph is shown. The arrow indicates the position
distribution of the MARCKS protein (Fig. 3A); i.e., the epi-of immunoprecipitated, phosphorylated MARCKS. The positions
of molecular weight standards are shown. tope-tagged protein was expressed at readily detectable lev-
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els in brain, spleen, testis, and lung, and at somewhat lower nounced defect in cortical lamination, most easily seen as
an irregular boundary between the cortical plate and thelevels in heart. These tissues normally express the highest
levels of MARCKS in the mouse, as determined by North- marginal zone in the developing forebrain (Stumpo et al.,
1995). Although the MACS-12CA5-rescued animals wereern blot analysis (Lobach et al., 1993). Expression of the
epitope-tagged protein was minimal in liver, skeletal mus- evaluated in adulthood, when the cortical plate and mar-
ginal zone are no longer present in the neocortex, coronalcle, and kidney, as seen with the endogenous mRNA (Lo-
bach et al., 1993). The pattern of expression was similar in sections displayed a normal boundary between the molecu-
lar layer (I) and the external granular layer in the frontalboth lines of mice (data not shown).
In addition to the normal pattern of tissue-speci®c expres- lobes (Figs. 5A±5C), indicating that cortical lamination was
not impaired.sion, the expressed, epitope-tagged human MARCKS pro-
tein was also primarily membrane-associated to approxi- Macs0/0 animals also displayed higher than normal fre-
quencies of certain birth defects, speci®cally exencephalymately the same extent as the endogenous protein (Fig. 3B).
Densitometric analysis of the Western blot shown in Fig. (25%) and omphalocele (19%) (Stumpo et al., 1995). Of 350
MACS-12CA5-rescued animals evaluated to date, no exen-3B indicated that 86% of the epitope-tagged protein was
associated with the particulate fraction, with the remainder cephaly or omphalocele has been observed.
Mice rescued with the MACS-12CA5 transgene exhibitassociated with the soluble fraction; 83% of the endogenous
protein was membrane-associated (Fig. 3B). The marked dif- normal retinal laminations. Macs0/0 animals also exhibit
lamination defects in the developing retina (Stumpo et al.,ference in Mr of the human transgenic protein compared to
the endogenous mouse protein allowed for the ready detec- 1995), speci®cally a near-absence of the layer of Chievitz,
which separates the inner and outer nuclear layers in fetaltion of both species in the same gel with the amino-terminal
MARCKS antibody (Fig. 3B). mice and neonatal mice (Chievitz, 1887; Smelser et al., 1973).
Although the MACS-12CA5-rescued animals were evaluatedExpression of the MACS-12CA5 transgene results in full
rescue of the Macs null phenotype. As reported earlier, tar- in adulthood, when the layer of Chievitz is no longer present
in the retina, retinas from these animals exhibited totally nor-geted disruption of Macs in mice and complete MARCKS
de®ciency resulted in perinatal death associated with serious mal patterns of retinal layering (Figs. 6a±6c).
Subcellular fractionation of nonmyristoylated humandefects in the development of the central nervous system
(Stumpo et al., 1995). Because the epitope-tagged human pro- MARCKS expressed in transgenic animals. Of ®ve lines
of mice generated that expressed detectable MACS(A2/G2)-tein exhibited a normal pattern of expression in the mouse,
we attempted to rescue the phenotype of the null mutation 12CA5 DNA, three lines were selected for further analysis
based on high level expression of nonmyristoylated humanwith the MACS-12CA5 transgene. Mice expressing both the
MACS-12CA5 transgene and one allele of disrupted Macs MARCKS protein. Animals expressing the MACS(A2/G2)-
12CA5 transgene appeared perfectly normal and did not ex-were mated to generate progeny that both expressed the
transgene and were homozygous for disrupted Macs; this geno- hibit any deleterious dominant negative effects caused by
high-level expression of the nonmyristoylated MARCKStype was con®rmed by Southern blot analysis. These mice
were not only viable, but also appeared perfectly normal in protein. These three lines of mice were used to determine
the subcellular localization of nonmyristoylated humansize and development of the central nervous system, as de-
scribed below. In addition, both sexes of MACS-12CA5-res- MARCKS expressed in transgenic animals. Upon fraction-
ation of brain extracts by ultracentrifugation, nonmyristoy-cued Macs 0/0 mice were fertile, and females were able to
sustain pregnancy with an average litter size of 4 { 2.4 (SD) lated human MARCKS was associated with both the soluble
and particulate fractions (Fig. 7A). Densitometric analysispups (n  87 litters). Perinatal death of knockout pups not
expressing the MACS-12CA5 transgene may account for the of the Western blot from the three different lines of mice
shown in Fig. 7A indicated that approximately 51, 57, andsmall average litter size. To date, the oldest living rescued
animals are 16 months of age. 52% (mean 53%) of the nonmyristoylated, epitope-tagged
protein was associated with the particulate fraction. ThisMice rescued with the MACS-12CA5 transgene exhibit
normal brain development. Several defects in brain devel- should be compared to the distribution of the endogenous,
fully myristoylated mouse protein evaluated in the sameopment are hallmarks of the MARCKS-de®cient phenotype
(Stumpo et al., 1995). For example, Macs 0/0 animals dis- blot, in which essentially all of the protein was associated
with the particulate fraction (Fig. 7A). These results indicateplayed agenesis of the corpus callosum and other forebrain
commissures, in addition to failure of fusion of the cerebral that, in contrast to both the endogenous mouse protein and
the transgenic wild-type human protein, a signi®cant por-hemispheres. Coronal sections of brains from adult MACS-
12CA5-rescued animals at approximately the level of the tion (40±50%) of nonmyristoylated MARCKS was associ-
ated with the soluble fraction prepared from brain extracts.optic chiasm indicated that normal fusion of the cerebral
hemispheres had taken place; in addition, the corpus callo- Immunohistochemistry of transgenic normal and nonmyri-
stoylated MARCKS. The antibody 12CA5 was used tosum as well as the anterior and ventral hippocampal com-
missures were intact (Figs. 4A±4C). evaluate the subcellular distribution of transgenic human
MARCKS, either wild-type or nonmyristoylated, in the devel-A universal ®nding in the Macs 0/0 animals is a pro-
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FIG. 4. Corpus callosum in MACS-12CA5-rescued animals. Portions of hematoxylin- and eosin-stained coronal sections of brains from
an adult wild-type or Macs /// mouse (A) and two adult MACS-12CA5-rescued, Macs 0/0 animals (B, C), all from the same litter, at
approximately the level of the optic chiasm are shown. CC, corpus callosum; AC, anterior commissure. Bar, 200 mm.
oping brains of E 9.5 transgenic mice. This early date was null phenotype. Every newborn mouse that expressed the
MACS(A2/G2)-12CA5 transgene and was homozygous forchosen because endogenous MARCKS can be localized clearly
the disrupted Macs gene exhibited normal fusion of theto the plasma membrane of individual cells at this time (Black-
cerebral hemispheres and formation of the corpus callosumshear et al., 1996). Epitope-tagged human MARCKS was
and the anterior and ventral hippocampal commissures (Fig.clearly associated with the plasma membrane of the neuroepi-
9). These animals also displayed normal patterns of corticalthelial, surface ectoderm, and mesenchymal cells (Fig. 8), a
lamination, as evidenced by the smooth boundary betweenpattern indistinguishable from that seen with endogenous
the marginal zone and the cortical plate in the neocortexmouse MARCKS (Blackshear et al., 1996). In contrast, the
(Fig. 10), and normal retinal layering, as evidenced by thenonmyristoylated human protein was clearly localized, at
presence of a well-developed layer of Chievitz (Fig. 11). Noleast in part, to the cytoplasm of all three types of cells (Fig.
instances of exencephaly or omphalocele have been ob-8). The speci®city of the antibody was indicated by the com-
served in these mice, in contrast to the high frequencies (25plete lack of staining of tissues from normal, nontransgenic
and 19%, respectively) of these defects in the Macs 0/0littermate embryos processed in parallel (Fig. 8).
mice (Stumpo et al., 1995). Newborn mice that were homo-Expression of the MACS(A2/G2)-12CA5 transgene fails to
zygous for the disrupted Macs gene, but did not express therescue completely the MARCKS null phenotype in 75%
MACS(A2/G2)-12CA5 transgene, exhibited the characteris-of animals. In order to determine if the absence of the
tic histological abnormalities associated with the Macsmyristoyl moiety would have any adverse effects on the 0/0 phenotype (data not shown).function of the MARCKS protein in development, we also
Interestingly, 25% of mice with the appropriate ``rescue''attempted to rescue the null phenotype with mice express-
genotype (7 of 28) were viable. To date, these survivinging the MACS(A2/G2)-12CA5 transgene. Expression of this
animals appear healthy and behaviorally and phenotypicallymutant gene product was at least as great as that of the
normal, except that they weigh, on average, about 23% lessnormal transgene product in whole brain homogenates (Fig.
than their littermates (Fig. 12). As determined by densito-7B). To date, 75% of mice with the appropriate ``rescue''
metric analysis of the Southern blots, the relative amountsgenotype (n 28 total whose genotype could be determined
of the transgene in the viable and nonviable animals werewith certainty) died before or shortly after birth, similar to
not signi®cantly different.the Macs 0/0 mice (Stumpo et al., 1995). These animals
appeared normal morphologically, but were never observed DISCUSSIONto have much milk in the stomach. However, these animals
did not exhibit any of the major histological defects in cen- These studies have demonstrated that expression of an
epitope-tagged, human MARCKS protein in Macs 0/0 ani-tral nervous system development associated with the Macs
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hibited normal rates of perinatal survival, and no instances
of exencephaly or omphalocele were detected. Finally, these
transgenically rescued animals appeared normal in every
way, including normal size and fertility. Because the Macs
0/0 animals examined in our previous studies were derived
from a single line of ES cells (Stumpo et al., 1995), the
possibility existed that the observed defects were not due
simply to MARCKS de®ciency. However, complete rescue
of the Macs 0/0 phenotype with the MACS-12CA5
transgene con®rms that MARCKS plays an integral role in
the development of the central nervous system, and that
the previously observed defects (Stumpo et al., 1995) were
indeed the result of MARCKS de®ciency alone. Complete
rescue of the Macs 0/0 phenotype with the MARCKS-
12CA5 protein also demonstrates that expression of the 9-
amino-acid hemagglutinin epitope tag at the carboxyl-ter-
minus of MARCKS had no deleterious effects on the normal
developmental function of the protein.
Complete rescue of the Macs 0/0 phenotype with the
MACS-12CA5 transgene also indicates that the 3.4 kb of
upstream MACS sequences was suf®cient to direct normal
spatial and temporal expression of the MARCKS-12CA5
protein during development. Previous studies examining
the promoter regions of human (Harlan et al., 1991) and
mouse (Blackshear et al., 1992) MARCKS have shown that
the 5*-¯anking regions are highly conserved (89% identical)
between the two species. Both promoters lack a TATA box
and include potential binding sites for transcription factors
SP1 and CTF/NF-1 (Mitchell and Tjian, 1989). In transient
transfections in LM/TK0 cells, 248 bp of upstream se-
quences was suf®cient to drive normal expression of a hu-
man growth hormone construct, whereas a construct con-
taining 110 bp of upstream sequences was essentially inac-
tive (Harlan et al., 1991). Although the MACS promoter
has not been characterized further, the present replacement
experiments indicate that 3.4 kb of upstream sequence,
combined with the endogenous intron and 3*-untranslated
region, contains all of the elements necessary for normal
MARCKS expression in the intact animal during develop-
ment.
These studies thus form the basis for experiments de-
signed to test the importance in development of speci®c
sequence elements within the MARCKS protein. In the ®rst
FIG. 5. Cortical laminations in MACS-12CA5-rescued animals. such test of ``structure±function'' relationships, we at-
Hematoxylin- and eosin-stained sections of neocortex from brains tempted to rescue the null phenotype with a transgenic
of the same littermates shown in Fig. 4, i.e., a wild-type Macs construct that was identical in every way to the construct///mouse (A) and two MACS-12CA5-rescued, Macs 0/0 animals that successfully complemented the null phenotype, except
(B, C), are shown. I, molecular layer. Bar, 50 mm.
for changes in two nucleotides that led to the gly2 r ala2
mutation, resulting in a nonmyristoylatable protein . Ex-
pression of this mutant protein in brain was at least as great
as that of the wild-type human protein that corrected themals resulted in full rescue of the neurodevelopmental de-
fects associated with the Macs 0/0 phenotype (Stumpo et null phenotype, as determined by immunoblotting. The
nonmyristoylated status of the protein was re¯ected in itsal., 1995). Mice expressing the MARCKS-12CA5 protein,
driven by 3.4 kb of the MACS promoter, exhibited intact approximately 50% representation in the brain cytosolic
fraction, compared with 14% of the normal human protein.forebrain commissures, fusion of the cerebral hemispheres,
and normal cortical and retinal laminations. They also ex- Although about 75% of the Macs 0/0 pups expressing this
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FIG. 6. Retinal layering in MACS-12CA5-rescued animals. Hematoxylin- and eosin-stained sections of retinas from the same littermates
shown in Figs. 4 and 5, i.e., a wild-type Macs /// mouse (a) and two MACS-12CA5-rescued Macs 0/0 animals (b, c), are shown. 1, sclera;
2, choroid plexus; 3, retinal pigment epithelium; 4, rod outer segment; 5, rod inner segment; 6, outer nuclear layer; 7, outer plexiform
layer; 8, inner nuclear layer; 9, inner plexiform layer; 10, ganglion cell layer; 11, retinal ganglion cell axons. Bar, 25 mm.
FIG. 12. Phenotype of MARCKS-de®cient mice expressing the MACS(A2/G2)-12CA5 transgene. Two mice of the Macs 0/0 genotype
expressing the MACS(A2/G2)-12CA5 transgene (ko-r) and a littermate of the Macs //0 genotype expressing the MACS(A2/G2)-12CA5
transgene (wt) at 3 weeks of age are shown. Their body weights were 8 g (for both ko-r mice) and 12 g (wt).
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animals to survive is most likely a stochastic phenomenon,
in that viable animals occurred randomly throughout the
population. Experiments currently underway involving in-
tercrosses of the rescued animals should help us to deter-
mine the true frequency of survivors in a large population,
and whether survival is random or implicates potential
modi®er genes.
To our knowledge, this is the ®rst report of an attempt
to rescue a null mutation in mice with the nonmyristoy-
lated form of a protein. However, complementation studies
have been performed with nonmyristoylated proteins in the
budding yeast, Saccharomyces cerevisiae (Johnson et al.,
1994). Myristoylation was shown to be essential for the
proper function of both the ADP-ribosylation factor, Arf1
(Kahn et al., 1995), and the pheromone-responsive G protein
a subunit, Gpa1 (Stone et al., 1991). Yeast cells expressing
nonmyristoylated Arf1 were not viable (Kahn et al., 1995),
and cells expressing nonmyristoylated Gpa1 exhibited con-
stitutive activation of the mating pathway (Stone et al.,
1991). On the other hand, a nonmyristoylated form of the
FIG. 7. Subcellular fractionation of MARCKS (A2/G2)-12CA5 in Vps15 protein kinase behaved essentially like wild-type
brain extracts. Brain homogenates from individual adult mice rep- Vps15 in yeast, although it was phosphorylated to a lesser
resenting three separate (1±3) lines of transgenic animals express- extent (Herman et al., 1991).
ing MARCKS(A2/G2)-12CA5 were separated into membrane (M) In higher eukaryotic cells, mutations preventing N-my-
and cytosolic (C) fractions by ultracentrifugation. The membrane ristoylation have been shown to affect the function of many
fraction was resuspended in the original volume of homogenization proteins. For example, nonmyristoylated forms of the gag
buffer, and then equal volumes were subjected to SDS±PAGE,
polyprotein precursors from human immunode®ciency vi-transferred to nitrocellulose, and probed with a polyclonal antibody
rus (Bryant and Ratner, 1990), Moloney murine leukemiaraised against a MARCKS amino-terminal peptide (A). The top
virus (Rein et al., 1986), and Mason±P®zer monkey virusarrow points to the nonmyristoylated human protein; the bottom
(Rhee and Hunter, 1987) were defective in assembly of thearrow points to the endogenous mouse protein. In B, brain homoge-
nates from adult mice expressing nonmyristoylated human mature virion and the production of infectious particles.
MARCKS (MARCKS (A2/G2)-12CA5) and wild-type human Myristoylation was also required for p60src (Cross et al.,
MARCKS (MARCKS-12CA5) were subjected to SDS±PAGE, trans- 1984; Buss et al., 1986) and p56lck (Abraham and Veillette,
ferred to nitrocellulose, and probed with a monoclonal antibody 1990) to transform cells. In addition, myristoylation was
raised against the hemagglutinin epitope tag. necessary for p60src to serve as a substrate for protein kinase
C (Buss et al., 1986). Nonmyristoylated ADP-ribosylation
factor 6 had no effect on internalization and recycling of
the transferrin receptor (D'Souza-Schorey and Stahl, 1995),mutant protein did not survive the perinatal period, the
25% that did were viable and phenotypically normal, al- indicating that myristoylation was required for this protein
to play its normal role in endocytic traf®cking.though modestly decreased in size relative to their lit-
termates. The females appear to be normal with respect to For other myristoyl proteins, myristoylation is required
for only a subset of their functions. For example, the cata-reproductive behavior and fertility. In addition, none of the
rescued animals (n 28) displayed any of the gross anatomi- lytic subunit of cAMP-dependent protein kinase does not
require myristate for holoenzyme formation (Clegg et al.,cal defects characteristic of the Macs 0/0 phenotype
(Stumpo et al., 1995). That the presence of MARCKS protein 1989; Yonemoto et al., 1993), activation of the enzyme
(Clegg et al., 1989; Slice and Taylor, 1989; Yonemoto etsequences per se is not suf®cient to complement the
MARCKS de®ciency phenotype is suggested by the fact that al., 1993), regulation of cell morphology (Clegg et al.,
1989), synthesis of steroids (Clegg et al., 1989), or regula-an otherwise identical transgene expressing a MARCKS±b-
gal fusion protein is totally ineffective at rescuing any as- tion of the expression of cellular genes (Clegg et al., 1989).
Instead, myristoylation appears to be required for thepects of the null phenotype (S. L. Swierczynski, W. S. Lai,
and P. J. Blackshear, submitted for publication). Therefore, structural stability of the catalytic subunit (Clegg et al.,
1989; Slice and Taylor, 1989; Yonemoto et al., 1993;we can conclude from these experiments that the myristoyl
modi®cation of the MARCKS protein is not necessary for Zheng et al., 1993). Nonmyristoylated p60src exhibits ty-
rosine kinase activity (Buss et al., 1986), yet displays themany of the developmental processes disrupted in the 0/0
mice, or for the postnatal survival of at least a substantial defects discussed above.
Previous studies of MARCKS myristoylation havefraction of these animals. The ability of a subset of these
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FIG. 8. Immunohistochemistry of coronal sections from E 9.5 mice expressing the MACS-12CA5 and MACS(A2/G2)-12CA5 transgenes.
Coronal sections of brains from E 9.5 mice of the Macs 0/0 genotype expressing the MACS-12CA5 transgene (A, neural tube; C,
mesenchyme), the Macs /// genotype expressing the MACS(A2/G2)-12CA5 transgene (B, neural tube; D, neural tube), and the Macs
/// genotype expressing no transgene (E, neural tube) incubated with the monoclonal antibody 12CA5 are shown. (F) A coronal section
from the mouse with the Macs /// genotype expressing the MACS(A2/G2)-12CA5 transgene that was not incubated with the 12CA5
antibody, but was otherwise processed in parallel with the other sections. As a secondary antibody for all sections, goat anti-mouse IgG
conjugated to ¯uorescein isothiocyanate was used. Bar, 25 mm.
demonstrated that myristoylation is necessary for the a brain membrane fraction, compared to 80% of the wild-
type protein. Nonetheless, nonmyristoylated MARCKSfull extent of MARCKS membrane association. For exam-
ple, in cell-free assays, nonmyristoylated MARCKS ex- can still serve as a substrate for PKC in intact cells (Graff
et al., 1989). In addition, the polybasic phosphorylationhibited markedly decreased af®nity for ®broblast mem-
branes when compared to the fully myristoylated protein site domain has been shown to exert an independent
membrane targeting effect, both in cell-free systems and(Swierczynski and Blackshear, 1995). In cell expression
studies, about 40% of the nonmyristoylated protein was in intact cells (Kim et al., 1994a,b; Swierczynski and
Blackshear, 1995, 1996). Therefore, it may be that enoughassociated with the plasma membrane, compared to 80%
of the wild-type protein. In the present study, about 50% of the nonmyristoylated protein can associate with the
plasma membrane in these rescued animals to subserveof the nonmyristoylated protein was still associated with
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phosphorylated by PKC have been mutated to aspartates
can complement any aspects of the null phenotype; this
double mutant protein has essentially no membrane af-
FIG. 9. Coronal sections from newborn MARCKS-de®cient mice
expressing the MACS(A2/G2)-12CA5 transgene. Hematoxylin- and
eosin-stained coronal sections of brains from newborn mice of the
Macs 0/0 genotype (A), Macs /// genotype (B), and the Macs 0/
0 genotype expressing the MACS(A2/G2)-12CA5 transgene (C) are
shown. The arrow indicates the persistent interhemispheric ®ssure
FIG. 10. Sections of lateral cortex from newborn MARCKS-de®cientin the 0/0 mouse; note also the absence of the corpus callosum
mice expressing the MACS(A2/G2)-12CA5 transgene. Hematoxylin-(CC) and the presence of Probst's bundles (P) in A. Bar, 200 mm.
and eosin-stained sections of the neocortex from newborn mice with
the Macs 0/0 genotype (A), Macs /// genotype (B), and the Macs
0/0 genotype expressing the MACS(A2/G2)-12CA5 transgene (C) are
many, if not all, of MARCKS's developmental functions. shown. Note the jagged boundary between the cortical plate and the
Future studies will address the question of whether a marginal zone in A, which is smooth in B and C. M, marginal zone;
CP, cortical plate; LV, lateral ventricle. Bar, 100 mm.nonmyristoylatable protein in which the four serines
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FIG. 11. Retinal sections from newborn MARCKS-de®cient mice expressing the MACS(A2/G2)-12CA5 transgene. Hematoxylin- and
eosin-stained sections of retina from newborn mice of the Macs 0/0 genotype (A), Macs /// genotype (B), and the Macs 0/0 genotype
expressing the MACS(A2/G2)-12CA5 transgene (C) are shown. The arrow indicates the transient layer of Chievitz, which is nearly absent
in A but is well-de®ned in B and C. Bar, 100 mm.
E., Nairn, A. C., and Sulik, K. K. (1996). Developmental expres-®nity, either in cell-free assays (Swierczynski and Black-
sion of MARCKS and protein kinase C in mice in relation toshear, 1995) or in cultured cells (Swierczynski and Black-
the exencephaly resulting from MARCKS de®ciency. Dev. Brainshear, 1996).
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